Showing results (21-30 of 339) with videos related to
Sort By:
Pageof 34
BMJ (Clinical Research Ed.)|April 1, 2016
New and emerging targeted therapies for cystic fibrosisBradley S Quon, Steven M RoweCurrent Opinion in Pulmonary Medicine|September 11, 2010
Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosisPeter A Sloane, Steven M RoweThe Journal of Clinical Investigation|September 17, 2019
Revealing the molecular signaling pathways of mucus stasis in cystic fibrosisSusan E Birket, Steven M RoweCold Spring Harbor Perspectives in Medicine|July 3, 2013
Cystic fibrosis transmembrane regulator correctors and potentiatorsSteven M Rowe, Alan S VerkmanPlos One|August 8, 2013
Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutationSteven M Rowe, Bo Liu, Aubrey Hill, et al.Clinics in Chest Medicine|November 7, 2022
Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance RegulatorsClemente J Britto, Felix Ratjen, John P ClancyQuality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2003
The Caregiver Quality of Life Cystic Fibrosis (CQOLCF) scale: modification and validation of an instrument to measure quality of life in cystic fibrosis family caregiversWhitney Boling, David M Macrina, John P ClancyExpert Opinion on Investigational Drugs|March 7, 2014
Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patientsZarmina Ehsan, Jacqueline Denise Wetzel, John P ClancyPediatric Pulmonology|March 19, 2019
Aerosolized agents for airway clearance in cystic fibrosisKevin W Southern, John P Clancy, Sarath RanganathanPediatric Pulmonology|September 8, 2017
Toward inclusive therapy with CFTR modulators: Progress and challengesJennifer Guimbellot, Jyoti Sharma, Steven M RowePageof 34